https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
Hydroxychloroquine or chloroquine with or without azithromycin have been widely promoted to treat coronavirus disease 2019 (COVID-19) following early invitro antiviral effects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aim of this systematic review and meta-analysis was to assess whether chloroquine or hydroxychloroquine with or without azithromycin decreased COVID-19 mortality compared with the standard of care. PubMed, Web of Science, Embase Cochrane Library, Google Scholar and MedRxiv
Like
Comment
Share
